1610.5000 8.50 (0.53%)
NSE Sep 16, 2025 15:31 PM
Volume: 1.5M
 

1610.50
0.53%
Sun Pharma may incur revenue loss for ransomware incident on March 2
Business Standard
Sun Pharma Advanced Research Company may incur expenses in connection with incident; India was the second most attacked country for ransomware in the APAC-Japan region in 2022
More from Sun Pharmaceutical Industries Ltd.
Recommended